Literature DB >> 6305226

Current trends in the diagnosis and treatment of carcinoma of the pancreas.

K W Warren, C Christophi, R Armendariz, S Basu.   

Abstract

Causes of diagnostic delay and survival figures were compared in three groups of patients (total 191 patients) with ductal adenocarcinoma of the pancreas between the years 1951 and 1960 and 1971 and 1980. The main causes of delay between onset of symptoms and definitive treatment were patient delay in seeking medical advice and delay by the initial doctor in referring the patient. Recent direct imaging techniques of ultrasound, computerized axial tomographic scanning, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography did not significantly decrease this diagnostic delay. Operative mortality in the groups treated by pancreatoduodenectomy between 1951 and 1960 and 1971 and 1980 were 13.9 and 3.4 percent, respectively. The mean survival rates for these groups were 14 and 20.4 months, respectively. Patients with unresectable carcinoma of the pancreas between 1971 and 1980 had an operative mortality rate of 10 percent and a mean survival of 6.7 months. Various aspects of symptomatology and operative findings in patients with carcinoma of the pancreas are emphasized to aid early diagnosis.

Entities:  

Mesh:

Year:  1983        PMID: 6305226     DOI: 10.1016/0002-9610(83)90149-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  11 in total

Review 1.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

2.  Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel.

Authors:  M Menges; H W Pees
Journal:  Int J Pancreatol       Date:  1999-12

3.  The pancreatic cancer problem.

Authors:  E M Livstone; H M Spiro
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

4.  Serologic markers in the diagnosis and management of pancreatic carcinoma.

Authors:  D K Podolsky
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

5.  Pancreaticogastrostomy after pancreaticoduodenectomy.

Authors:  J W Bradbeer; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

Review 6.  Overview of pancreatic cancer, 1989.

Authors:  I Cohn
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

7.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

8.  [Perioperative staging and the Münster TNM classification in ampullary and pancreatic cancer].

Authors:  M Clemens; J Meyer; U Sulkowski; W Sasse; H Bünte
Journal:  Langenbecks Arch Chir       Date:  1985

9.  Digestive and nutritional consequences of pancreatic resections. The classical vs the pylorus-sparing procedure.

Authors:  F Crucitti; G Doglietto; R Bellantone; G A Miggiano; D Frontera; A M Ferrante; A Castelli
Journal:  Int J Pancreatol       Date:  1995-02

10.  Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer.

Authors:  E Angst; S Sibold; C Tiffon; R Weimann; B Gloor; D Candinas; D Stroka
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.